• Science and Research

  Antabio Awarded $4.4M for Continued Research for CF Lung Infection Therapy

  Posted by Cystic Fibrosis News Moderator on January 21, 2020 at 8:56 am

  

  Antabio has received $4.4 million to continue its research for a therapy against Pseudomonas aeruginosa lung infections in people with cystic fibrosis. Click here to learn more.

  What do you think of this news?

  Cystic Fibrosis News Moderator replied 4 years, 10 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply